[ad_1]
Modern American Biotechnology announced that the adult vaccination success rate was 94.1 percent in the final results of third-stage clinical trials that took place in 30,000 participants two weeks ago. The company then applied for emergency use approval from the US Food and Drug Administration (FDA) and the European Medicines Agency (USA).
However, the 95 percent effective vaccine developed by competitor Pfizer / BionTech using a method similar to Moderna was approved in England last Tuesday and began to be used in the country. However, this has raised questions about the safety of vaccines in children. Because until now, no company or institute has included children in clinical trials.
OVER 3 THOUSAND CHILDREN
Moderna said that in this context, a clinical trial began in the United States that will include 3,000 healthy children between the ages of 12 and 18 years. In the statement made, it was indicated that the experiments continued in the mid-late stage, and it was indicated that the first dose of the first vaccine called mRNA-1273 was administered to a group of children and the second dose would be administered at 28 days .
However, the US Food and Drug Advisory Committee (FDA) will meet on December 17 to discuss the approval of Moderna’s vaccine and its work in adolescents. “Our goal is to generate data to support the use of mRNA-1273 in adolescents before next year’s school year, that is, in spring 2021,” Moderna CEO Stephane Bancel said in a statement. used expressions. Schools in the United States generally open in August or September.
THE RESULTS OF THE PFIZER / BİONTECH TEST WITH CHILDREN HAVE NOT YET BEEN SHARED
On the other hand, the American pharmaceutical company Pfizer announced in October that it will test the corona virus vaccine developed with the German biotechnology company BionTech, of which the Turkish professor Uğur Şahin is a founding partner, in children aged 12 and over 12 years. However, there were no further explanations as to whether or not the study started.
In October, the FDA’s advisory council made up of independent experts from Pfizer / BioNTech authorized the FDA for the urgent use of the Covid-19 vaccine developed by the pharmaceutical company Pfizer and BioNTech with a vote of 4-17 after the meeting. from yesterday. FDA approval is expected to arrive in the next few days.
ESPERANZA MEDICINE AGAINST THE VIRUS
